Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana

Affiliations

• ¹ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ² South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: [email protected].
• ³ Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States; University of Botswana, Gaborone, Botswana. Electronic address: [email protected].
• ⁴ Medical Evidence, Vaccine and Immune Therapies, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK. Electronic address: [email protected].
• ⁵ Medical and Payer Evidence Statistics, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK. Electronic address: [email protected].
• ⁶ Late Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: [email protected].
• ⁷ Ministry of Health Botswana, Botswana. Electronic address: [email protected].
• ⁸ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ⁹ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁰ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹¹ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹² Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹³ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁴ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁵ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁶ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁷ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁸ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ¹⁹ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²⁰ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²¹ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²² Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²³ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²⁴ Botswana Harvard AIDS Institute Partnership, Botswana.
• ²⁵ Infection Evidence Strategy, Vaccine and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK. Electronic address: [email protected].
• ²⁶ Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: [email protected].
• ²⁷ Botswana Harvard AIDS Institute Partnership, Botswana; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States. Electronic address: [email protected].
• ²⁸ Botswana Harvard AIDS Institute Partnership, Botswana; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States. Electronic address: [email protected].